RAGE and its ligands in cancer - culprits, biomarkers, or therapeutic targets?

被引：27

作者：

Tesarova, P. ^{[1
,2
]}

Cabinakova, M. ^{[1
,2
]}

Mikulova, V. ^{[2
,3
]}

Zima, T. ^{[2
,3
]}

Kalousova, M. ^{[2
,3
]}

机构：

[1] Charles Univ Prague, Dept Oncol, Fac Med 1, Prague, Czech Republic

[2] Gen Univ Hosp, Prague, Czech Republic

[3] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague, Czech Republic

来源：

NEOPLASMA | 2015年 / 62卷 / 03期

关键词：

RAGE; cancer; HMGB1; S100; proteins; GLYCATION END-PRODUCTS; ALTERNATIVELY SPLICED RAGEV1; SOLUBLE FORM SRAGE; ENDPRODUCTS RAGE; MELANOMA GROWTH; RECEPTOR; EXPRESSION; RISK; POLYMORPHISM; AGES;

D O I：

10.4149/neo_2015_061

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Receptor for advanced glycation end products (RAGE) plays a central role in the regulation of tissue homeostasis, regeneration and resolution of inflammation, but under pathological conditions RAGE-mediated pathways may induce diminished apoptosis, but enhanced autophagy and cell necrosis. These mechanisms may contribute to malignant transformation, cancer progression and metastases. Soluble RAGE may bind natural RAGE ligands and counteract some of the RAGE-mediated effects. Activation of RAGE was demonstrated in different types of cancer (including colon, pancreatic and breast cancer). Expression of RAGE and serum levels of soluble RAGE may serve as cancer biomarkers and strategies aimed at interfering with RAGE signaling might be promising anticancer drugs.

引用

页码：353 / 364

页数：12

共 78 条

[1] Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions [J].

Abe, R ;

Shimizu, T ;

Sugawara, H ;

Watanabe, H ;

Nakamura, H ;

Choei, H ;

Sasaki, N ;

Yamagishi, SI ;

Takeuchi, M ;

Shimizu, H .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (02) :461-467

[2] V domain of RAGE interacts with AGEs on prostate carcinoma cells [J].

Allmen, Edith Uetz-von ;

Koch, Michael ;

Fritz, Guenter ;

Legler, Daniel F. .

PROSTATE, 2008, 68 (07) :748-758

[3] Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy [J].

Arumugam, Thiruvengadam ;

Ramachandran, Vijaya ;

Sun, Duoli ;

Peng, Zhenghong ;

Pal, Ashutosh ;

Maxwell, David S. ;

Bornmann, William G. ;

Logsdon, Craig D. .

MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05) :654-662

[4] S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis [J].

Arumugam, Thiruvengadam ;

Ramachandran, Vijaya ;

Gomez, Sobeyda B. ;

Schmidt, Ann M. ;

Logsdon, Craig D. .

CLINICAL CANCER RESEARCH, 2012, 18 (16) :4356-4364

[5] Understanding RAGE, the receptor for advanced glycation end products [J].

Bierhaus, A ;

Humpert, PM ;

Morcos, M ;

Wendt, T ;

Chavakis, T ;

Arnold, B ;

Stern, DM ;

Nawroth, PP .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11) :876-886

[6] RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis [J].

Dahlmann, Mathias ;

Okhrimenko, Anna ;

Marcinkowski, Patrick ;

Osterland, Marc ;

Herrmann, Pia ;

Smith, Janice ;

Heizmann, Claus W. ;

Schlag, Peter M. ;

Stein, Ulrike .

ONCOTARGET, 2014, 5 (10) :3220-3233

[7] Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells [J].

de Bittencourt Pasquali, Matheus Augusto ;

Gelain, Daniel Pens ;

Zeidan-Chulia, Fares ;

Pires, Andre Simoes ;

Gasparotto, Juciano ;

Terra, Silvia Resende ;

Fonseca Moreira, Jose Claudio .

CELLULAR SIGNALLING, 2013, 25 (04) :939-954

[8] Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth [J].

Elangovan, Indira ;

Thirugnanam, Sivasakthivel ;

Chen, Aoshuang ;

Zheng, Guoxing ;

Bosland, Maarten C. ;

Kajdacsy-Balla, Andre ;

Gnanasekar, Munirathinam .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (04) :1133-1138

[9] RAGE: a single receptor fits multiple ligands [J].

Fritz, Guenter .

TRENDS IN BIOCHEMICAL SCIENCES, 2011, 36 (12) :625-632

[10] The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case-Control Study within the Prospective EPIC Cohort [J].

Grote, Verena A. ;

Nieters, Alexandra ;

Kaaks, Rudolf ;

Tjonneland, Anne ;

Roswall, Nina ;

Overvad, Kim ;

Nielsen, Michael R. Skjelbo ;

Clavel-Chapelon, Francoise ;

Boutron-Ruault, Marie Christine ;

Racine, Antoine ;

Teucher, Birgit ;

Lukanova, Annekatrin ;

Boeing, Heiner ;

Drogan, Dagmar ;

Trichopoulou, Antonia ;

Trichopoulos, Dimitrios ;

Lagiou, Pagona ;

Palli, Domenico ;

Sieri, Sabina ;

Tumino, Rosario ;

Vineis, Paolo ;

Mattiello, Amalia ;

Argueelles Suarez, Marcial Vicente ;

Duell, Eric J. ;

Sanchez, Maria-Jose ;

Dorronsoro, Miren ;

Huerta Castano, Jose Maria ;

Barricarte, Aurelio ;

Jeurnink, Suzanne M. ;

Peeters, Petra H. M. ;

Sund, Malin ;

Ye, Weimin ;

Regner, Sara ;

Lindkvist, Bjorn ;

Khaw, Kay-Tee ;

Wareham, Nick ;

Allen, Naomi E. ;

Crowe, Francesca L. ;

Fedirko, Veronika ;

Jenab, Mazda ;

Romaguera, Dora ;

Siddiq, Afshan ;

Bueno-de-Mesquita, H. Bas ;

Rohrmann, Sabine .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (04) :619-628

← 1 2 3 4 5 6 7 8 →